Sanofi teams with non-profit on a landmark new drug for sleeping sickness

Sanofi teams with non-profit on a landmark new drug for sleeping sickness

Source: 
Endpoints
snippet: 

The EMA has offered its endorsement for fexinidazole, which is billed as the first all-oral drug for sleeping sickness.